Insulin oral - Shanghai Biolaxy
Alternative Names: NodlinLatest Information Update: 21 Jan 2022
Price :
$50 *
At a glance
- Originator Shanghai Biolaxy
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Diabetes-mellitus in China (PO, Capsule)
- 06 Apr 2016 Phase I development is ongoing in China